Trial NCT00243035

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02675
Secondary IDs: 7032 CDR0000446083 MCC-VEL-04-111 NCI-2012-02675 NCI-7032 R01CA083978 VEL-04-111

Last trial update was posted on 2013-10-08

MeSH Interventions

Bortezomib Tipifarnib

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Refractory Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID